PAR paradigm biopharmaceuticals limited..

The Ghosh Study - PART 1, page-39

  1. 140 Posts.
    lightbulb Created with Sketch. 37
    I think Dungiven is right on the money there.
    If the board didnt approve the non binding offer, then they wouldnt have been given access. Its all in the slides.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
43.0¢
Change
0.000(0.00%)
Mkt cap ! $170.8M
Open High Low Value Volume
43.0¢ 43.0¢ 41.5¢ $141.6K 337.6K

Buyers (Bids)

No. Vol. Price($)
1 9738 41.5¢
 

Sellers (Offers)

Price($) Vol. No.
43.0¢ 76716 4
View Market Depth
Last trade - 16.10pm 25/07/2025 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.